Literature DB >> 25076008

Extreme pain from brown recluse spider bites: model for cytokine-driven pain.

Katie S Payne1, Karen Schilli1, Katlyn Meier1, Ryan K Rader2, Jonathan A Dyer3, James W Mold4, Jonathan A Green5, William V Stoecker6.   

Abstract

IMPORTANCE: Bites from the brown recluse spider (BRS) can cause extreme pain. We propose cytokine release as a cause of the discomfort and a central mechanism through glial cell upregulation to explain measured pain levels and time course. OBSERVATIONS: Twenty-three BRS bites were scored at a probable or documented level clinically, and an enzyme-linked immunosorbent assay was used to confirm the presence of BRS venom. The mean (SD) pain level in these cases 24 hours after the spider bite was severe: 6.74 (2.75) on a scale of 0 to 10. Narcotics may be needed to provide relief in some cases. The difference in pain level by anatomic region was not significant. Escalation observed in 22 of 23 cases, increasing from low/none to extreme within 24 hours, is consistent with a cytokine pain pattern, in which pain increases concomitantly with a temporal increase of inflammatory cytokines. CONCLUSIONS AND RELEVANCE: These findings in BRS bites support the hypothesis of cytokine release in inflammatory pain. A larger series is needed to confirm the findings reported here. The extreme pain from many BRS bites motivates us to find better prevention and treatment techniques.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25076008      PMCID: PMC4229416          DOI: 10.1001/jamadermatol.2014.605

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


  14 in total

Review 1.  Cytokines, inflammation, and pain.

Authors:  Jun-Ming Zhang; Jianxiong An
Journal:  Int Anesthesiol Clin       Date:  2007

Review 2.  Cut points on 0-10 numeric rating scales for symptoms included in the Edmonton Symptom Assessment Scale in cancer patients: a systematic review.

Authors:  Wendy H Oldenmenger; Pleun J de Raaf; Cora de Klerk; Carin C D van der Rijt
Journal:  J Pain Symptom Manage       Date:  2012-09-25       Impact factor: 3.612

3.  Loxosceles spider venom induces the production of alpha and beta chemokines: implications for the pathogenesis of dermonecrotic arachnidism.

Authors:  H F Gomez; M J Miller; A Desai; J S Warren
Journal:  Inflammation       Date:  1999-06       Impact factor: 4.092

4.  Diagnosis of loxoscelism in a child confirmed with an enzyme-linked immunosorbent assay and noninvasive tissue sampling.

Authors:  William V Stoecker; Jonathan A Green; Hernan F Gomez
Journal:  J Am Acad Dermatol       Date:  2006-09-01       Impact factor: 11.527

Review 5.  The clinical characteristics of brown recluse spider bites treated by family physicians: an OKPRN Study. Oklahoma Physicians Research Network.

Authors:  J Cacy; J W Mold
Journal:  J Fam Pract       Date:  1999-07       Impact factor: 0.493

6.  MCP-1 and IL-8 as pain biomarkers in fibromyalgia: a pilot study.

Authors:  Dennis C Ang; Michele N Moore; Janna Hilligoss; Rebeka Tabbey
Journal:  Pain Med       Date:  2011-06-30       Impact factor: 3.750

Review 7.  Glia and pain: is chronic pain a gliopathy?

Authors:  Ru-Rong Ji; Temugin Berta; Maiken Nedergaard
Journal:  Pain       Date:  2013-06-20       Impact factor: 6.961

8.  Seasonality of brown recluse populations is reflected by numbers of brown recluse envenomations.

Authors:  R K Rader; W V Stoecker; J M Malters; M T Marr; J A Dyer
Journal:  Toxicon       Date:  2012-03-21       Impact factor: 3.033

Review 9.  Targeting astrocyte signaling for chronic pain.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

10.  Elevated interleukin-8 enhances prefrontal synaptic transmission in mice with persistent inflammatory pain.

Authors:  Guang-bin Cui; Jia-ze An; Nan Zhang; Ming-gao Zhao; Shui-bing Liu; Jun Yi
Journal:  Mol Pain       Date:  2012-02-12       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.